Akebia Ther Stock Total Debt
| AKBA Stock | USD 1.88 0.06 3.30% |
Akebia Ther fundamentals help investors to digest information that contributes to Akebia Ther's financial success or failures. It also enables traders to predict the movement of Akebia Stock. The fundamental analysis module provides a way to measure Akebia Ther's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akebia Ther stock.
The current year's Total Debt To Capitalization is expected to grow to 1.58. Akebia | Total Debt |
Akebia Ther Company Total Debt Analysis
Akebia Ther's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Akebia Ther Total Debt | 104.18 M |
Most of Akebia Ther's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akebia Ther is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Akebia Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Akebia Ther is extremely important. It helps to project a fair market value of Akebia Stock properly, considering its historical fundamentals such as Total Debt. Since Akebia Ther's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Akebia Ther's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Akebia Ther's interrelated accounts and indicators.
Click cells to compare fundamentals
Akebia Total Debt Historical Pattern
Today, most investors in Akebia Ther Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akebia Ther's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Akebia Ther total debt as a starting point in their analysis.
Akebia Ther Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Akebia Net Debt
Net Debt |
|
Based on the latest financial disclosure, Akebia Ther has a Total Debt of 104.18 M. This is 96.21% lower than that of the Biotechnology sector and 67.92% lower than that of the Health Care industry. The total debt for all United States stocks is 98.04% higher than that of the company.
Akebia Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akebia Ther's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akebia Ther could also be used in its relative valuation, which is a method of valuing Akebia Ther by comparing valuation metrics of similar companies.Akebia Ther is currently under evaluation in total debt category among its peers.
Akebia Ther Current Valuation Drivers
We derive many important indicators used in calculating different scores of Akebia Ther from analyzing Akebia Ther's financial statements. These drivers represent accounts that assess Akebia Ther's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Akebia Ther's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 748.3M | 387.7M | 375.0M | 105.5M | 232.5M | 443.8M | |
| Enterprise Value | 709.1M | 285.3M | 361.3M | 114.8M | 293.7M | 394.5M |
Akebia Ther Institutional Holders
Institutional Holdings refers to the ownership stake in Akebia Ther that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Akebia Ther's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Akebia Ther's value.| Shares | Federated Hermes Inc | 2024-09-30 | 868 K | Fmr Inc | 2024-09-30 | 682 K | Bank Of New York Mellon Corp | 2024-06-30 | 604.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 568.7 K | Nuveen Asset Management, Llc | 2024-06-30 | 380.5 K | Goldman Sachs Group Inc | 2024-06-30 | 348.9 K | Susquehanna International Group, Llp | 2024-06-30 | 248.8 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 247.1 K | Rhumbline Advisers | 2024-06-30 | 247.1 K | Blackrock Inc | 2024-06-30 | 11.6 M | Vanguard Group Inc | 2024-09-30 | 10.1 M |
Akebia Fundamentals
| Return On Equity | -5.53 | ||||
| Return On Asset | -0.0937 | ||||
| Profit Margin | (0.27) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 411.65 M | ||||
| Shares Outstanding | 218.18 M | ||||
| Shares Owned By Insiders | 2.09 % | ||||
| Shares Owned By Institutions | 27.28 % | ||||
| Number Of Shares Shorted | 14.84 M | ||||
| Price To Earning | (4.84) X | ||||
| Price To Book | 4.12 X | ||||
| Price To Sales | 2.34 X | ||||
| Revenue | 194.62 M | ||||
| Gross Profit | 140.04 M | ||||
| EBITDA | (6.87 M) | ||||
| Net Income | (51.92 M) | ||||
| Cash And Equivalents | 143.89 M | ||||
| Cash Per Share | 0.78 X | ||||
| Total Debt | 104.18 M | ||||
| Debt To Equity | 2.15 % | ||||
| Current Ratio | 1.30 X | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (23.38 M) | ||||
| Short Ratio | 8.89 X | ||||
| Earnings Per Share | (0.22) X | ||||
| Target Price | 5.5 | ||||
| Number Of Employees | 167 | ||||
| Beta | 0.73 | ||||
| Market Capitalization | 397.09 M | ||||
| Total Asset | 241.7 M | ||||
| Retained Earnings | (1.61 B) | ||||
| Working Capital | 18.28 M | ||||
| Current Asset | 141.02 M | ||||
| Current Liabilities | 11.87 M | ||||
| Net Asset | 241.7 M |
About Akebia Ther Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akebia Ther's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akebia Ther using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akebia Ther based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:Check out Akebia Ther Piotroski F Score and Akebia Ther Altman Z Score analysis. For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.22) | Revenue Per Share 0.834 | Quarterly Revenue Growth (0.11) | Return On Assets (0.09) | Return On Equity (5.53) |
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.